US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

MRNA

Moderna (MRNA)

Moderna Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MRNA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/30	05 : 54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/11/30	05 : 49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/11/30	05 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/11/13	06 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/11/12	23 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc
2024/11/08	21 : 30	PR Newswire (US)	Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma	NASDAQ:MRNA	Moderna Inc
2024/11/08	06 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MRNA	Moderna Inc
2024/11/07	20 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRNA	Moderna Inc
2024/11/07	20 : 19	IH Market News	U.S. Futures Rise as Investors Await Fed Rate Decision; Oil Prices Drop	NASDAQ:MRNA	Moderna Inc
2024/11/06	20 : 09	IH Market News	Trump Media Shares Surge 32% Pre-Market; Tesla Jumps 13%; Coinbase Rises with BTC All-Time High	NASDAQ:MRNA	Moderna Inc
2024/11/05	23 : 05	PR Newswire (US)	Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024	NASDAQ:MRNA	Moderna Inc
2024/10/28	19 : 45	Business Wire	Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)	NASDAQ:MRNA	Moderna Inc
2024/10/23	21 : 00	PR Newswire (US)	Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence	NASDAQ:MRNA	Moderna Inc
2024/10/09	05 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/10/07	18 : 45	PR Newswire (US)	Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA	NASDAQ:MRNA	Moderna Inc
2024/10/04	21 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/10/04	21 : 49	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/10/03	21 : 00	PR Newswire (US)	Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors	NASDAQ:MRNA	Moderna Inc
2024/10/02	20 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRNA	Moderna Inc
2024/09/30	18 : 45	PR Newswire (US)	MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	NASDAQ:MRNA	Moderna Inc
2024/09/26	18 : 45	PR Newswire (US)	Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More	NASDAQ:MRNA	Moderna Inc
2024/09/23	18 : 45	PR Newswire (US)	Moderna, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA	NASDAQ:MRNA	Moderna Inc
2024/09/19	18 : 45	PR Newswire (US)	The Gross Law Firm Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA	NASDAQ:MRNA	Moderna Inc
2024/09/16	18 : 45	PR Newswire (US)	MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	NASDAQ:MRNA	Moderna Inc
2024/09/13	19 : 12	IH Market News	OpenAI Unveils Strawberry AI Model Series; Boeing Stock Falls 4% Amid Strike; HR Surges 20% on Growth Forecast	NASDAQ:MRNA	Moderna Inc
2024/09/12	19 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRNA	Moderna Inc
2024/09/12	18 : 45	PR Newswire (US)	Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRNA	NASDAQ:MRNA	Moderna Inc
2024/09/11	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNA	Moderna Inc
2024/09/10	20 : 30	PR Newswire (US)	Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases	NASDAQ:MRNA	Moderna Inc
2024/09/10	04 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRNA	Moderna Inc

Showing the most relevant articles for your search:NASDAQ:MRNA

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Yen

Bank of America

US Dollar vs Sterling

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約